<DOC>
<DOCNO>EP-0652209</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Derivatives of N-epsilon alkoxy-or alkenoxy-carbonyl lysine, their preparation and use in cosmetic, pharmaceutical, hygiene or alimentary compositions
</INVENTION-TITLE>
<CLASSIFICATIONS>A61Q1500	A61Q1100	C07C27100	A61K830	A61Q1500	A61K800	A61K4718	A61K844	A61Q114	A61K830	A61Q106	A61K800	A61Q112	A61Q100	A61Q1100	A61K930	C07C27122	A61Q110	A61K4716	A61K829	A61K930	A61Q102	A61Q100	A61Q114	A61Q112	A61K819	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61Q	A61Q	C07C	A61K	A61Q	A61K	A61K	A61K	A61Q	A61K	A61Q	A61K	A61Q	A61Q	A61Q	A61K	C07C	A61Q	A61K	A61K	A61K	A61Q	A61Q	A61Q	A61Q	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61Q15	A61Q11	C07C271	A61K8	A61Q15	A61K8	A61K47	A61K8	A61Q1	A61K8	A61Q1	A61K8	A61Q1	A61Q1	A61Q11	A61K9	C07C271	A61Q1	A61K47	A61K8	A61K9	A61Q1	A61Q1	A61Q1	A61Q1	A61K8	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Lysine derivatives containing an N
<
 epsilon 
>
-alkoxy- or -alkenoxycarbonyl group of formula: 
<
IMAGE
>
  in which: R represents a linear or branched C13-C24 alkyl radical, the C16 radical being branched, or a linear or branched C8-C24 alkenyl radical, and the salts of the said compounds of formula (I) and their optical isomers of D or L configuration or their mixtures. Use as ingredient in cosmetic, pharmaceutical, hygiene (health) or food compositions.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
OREAL
</APPLICANT-NAME>
<APPLICANT-NAME>
L'OREAL
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
BORDIER THIERRY
</INVENTOR-NAME>
<INVENTOR-NAME>
PHILIPPE MICHEL
</INVENTOR-NAME>
<INVENTOR-NAME>
BORDIER, THIERRY
</INVENTOR-NAME>
<INVENTOR-NAME>
PHILIPPE, MICHEL
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Lysine derivatives containing an N
ε
-alkoxy or N
ε
-alkenoxycarbonyl
group of formula:



in which:

R represents a linear or branched C
13
-C
24
 alkyl radical,
the C
16
 radical being branched, or a linear or branched
C
8
-C
24
 alkenyl radical, and the salts of the said compounds
of formula (I) as well as their optical isomers of

D or L configuration or their mixtures.
Lysine derivatives according to Claim 1, characterized
in that the said salts are salts of inorganic or

organic cations.
Lysine derivatives according to either of
Claims 1 and 2, characterized in that they are chosen

from the group consisting of N
ε
-2-hexyldecyloxycarbonyl-L-lysine,
N
ε
-2-decyltetradecyloxycarbonyl-L-lysine and
N
ε
-tetradecyloxycarbonyl-L-lysine.
Lysine derivatives according to any one of the
preceding claims, characterized in that the said derivatives

have a melting point greater than 250°C and have a
particle size of between 10 nm and 500 µm and preferably

between 0.1 and 25 µm.
Process for the preparation of the lysine 
derivatives of formula (I) as defined according to any

one of the preceding claims, characterized in that it
consists in reacting lysine or one of its salts, of known

configuration, in aqueous medium and at basic pH, with a
solution of a copper salt, in then reacting the solution

of the copper complex thus obtained, of formula:


with a compound of formula:


in which:

R is as defined according to Claim 1,
and X is chosen from the group consisting of a chlorine
atom, a chloromethyl radical and an imidazolyl radical,

the said compound of formula (III) being added without
solvent, and
in treating the copper salt of the N
ε
-substituted lysine
thus obtained with a decomplexing agent
and, optionally, in purifying the compound obtained.
Preparation process according to Claim 5, characterized
in that the said copper salt solution is a copper

sulphate solution.
Preparation process according to either of
Claims 5 and 6, characterized in that the decomplexing

agent is an aqueous solution of the disodium salt of
ethylenediaminetetraacetic acid.
Cosmetic, pharmaceutical, hygiene or food composition,
characterized in that it contains a lysine

derivative corresponding to the following formula: 


in which:

R' represents a linear or branched C
8
-C
24
 alkyl or alkenyl
radical, and the salts of the said compounds of formula

(I') as well as their optical isomers of D or L
configuration or their mixtures.
Composition according to Claim 8, characterized
in that the lysine derivative of formula (I') is chosen

from the group consisting of N
ε
-2-ethylhexyloxycarbonyl-L-lysine,
N
ε
-dodecyloxycarbonyl-L-lysine, N
ε
 -hexadecyloxycarbonyl-L-lysine,
N
ε
-decyloxycarbonyl-L-lysine,
N
ε
-2-butyloctyloxycarbonyl-L-lysine, N
ε
-2-hexyldecyloxycarbonyl-L-lysine,
N
ε
 -2-decyltetradecyloxycarbonyl-L-lysine
and N
ε
 -tetradecyloxycarbonyl-L-lysine.
Composition according to Claim 8 or 9, characterized
in that the said lysine derivative is present in

a proportion of between 0.05% and 80% by weight with
respect to the total weight of the composition.
Composition according to any one of Claims 8 to
10, characterized in that the said lysine derivative is

present in a proportion of between 1% and 30% by weight
with respect to the total weight of the composition.
Composition according to any one of Claims 8 to
11, characterized in that it additionally contains at

least one additive chosen from the group consisting of
surface-active agents, fatty substances, organic solvents,

silicones, thickeners, emollients, sunscreening
agents, treating agents, anti-foaming agents,

moisturizing agents, fragrances, preservatives, anti-oxidizing
agents, sequestrants, flavouring agents,

basifying or acidifying agents, fillers and inorganic or
organic powders. 
Use of a lysine derivative corresponding to the
formula (I') according to Claims 8 and 9 as substance for

coating substrate particles.
Use of a lysine derivative according to Claim 13,
characterized in that the substrate particles are chosen

from optionally coloured insoluble fillers.
Use of a lysine derivative according to Claim 14,
characterized in that the said fillers are chosen from

metal oxides of zinc, iron, titanium, manganese, cerium
and/or zirconium, and their nanopigments, or nylon,

polyethylene, mica or talc powders.
</CLAIMS>
</TEXT>
</DOC>
